Preoperative Cardiac Risk Assessment and Management of Elderly Men with an Abdominal Aortic Aneurysm

Chapter

References

  1. 1.
    Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72(1):153–84.CrossRefPubMedGoogle Scholar
  2. 2.
    Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–33.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Thygesen K, Alpert JS, Jaffe AS, et al. Writing group on the joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Galal W, Hoeks SE, Flu WJ, et al. Relation between preoperative and intraoperative new wall motion abnormalities in vascular surgery patients: a transesophageal echocardiographic study. Anesthesiology. 2010;112:557–66.CrossRefPubMedGoogle Scholar
  5. 5.
    Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol. 1996;57(1):37–44.CrossRefPubMedGoogle Scholar
  6. 6.
    Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154(8):523–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Botto F, Alonso-Coello P, Chan MTV, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564–78.CrossRefPubMedGoogle Scholar
  8. 8.
    Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery––executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105(10):1257–67.PubMedGoogle Scholar
  9. 9.
    Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335(23):1713–20.CrossRefPubMedGoogle Scholar
  10. 10.
    Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341(24):1789–94.CrossRefPubMedGoogle Scholar
  11. 11.
    Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–47.CrossRefPubMedGoogle Scholar
  12. 12.
    Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2246–64.CrossRefPubMedGoogle Scholar
  13. 13.
    Kristensen SD, et al. The 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment andmanagement. The joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383–243.CrossRefPubMedGoogle Scholar
  14. 14.
    Huhle G, Abletshauser C, Mayer N, Weidinger G, Harenberg J, Heene DL. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor. Thromb Res. 1999;95(5):229–34.CrossRefPubMedGoogle Scholar
  15. 15.
    Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl- CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998;101(12):2711–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Antoniou GA, Hajibandeh S, Hajibandeh S, et al. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery. J Vasc Surg. 2015;61:519–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Schouten O, Boersma E, Hoeks SE, et al. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Nissen SE, Stroes E, Dent-Acosta RE, on behalf of the GAUSS-3 Investigators, et al. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 Randomized Clinical Trial. JAMA. 2016;315:1580–90.CrossRefPubMedGoogle Scholar
  19. 19.
    Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med. 2005;257:399–414.CrossRefPubMedGoogle Scholar
  20. 20.
    Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494–503.CrossRefPubMedGoogle Scholar
  21. 21.
    Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. BRIDGE investigators. N Engl J Med. 2015;373:823–33.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists; Systematic review and meta-analysis of bleeding and tromboembolic rates. Circulation 2012;126:1630–1639.Google Scholar
  23. 23.
    Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511–20.CrossRefPubMedGoogle Scholar
  24. 24.
    Huisman MV, Fanikos J. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols. Am J Med. 2016;129:S89–96.CrossRefPubMedGoogle Scholar
  25. 25.
    Hwang JW, Kim EK, Yang JH, et al. Assessment of perioperative cardiac risk of patients undergoing noncardiac surgery using coronary computed tomographic angiography. Circ Cardiovasc Imaging. 2015;8:1–10.CrossRefGoogle Scholar
  26. 26.
    McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–804.CrossRefPubMedGoogle Scholar
  27. 27.
    EY W, Lawrence HP, Wong DT. The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery––a meta-analysis. Can J Anaesth. 2007;54:705–17.CrossRefGoogle Scholar
  28. 28.
    Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288–94.CrossRefPubMedGoogle Scholar
  29. 29.
    Savonitto S, D’Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth. 2010;104:285–91.CrossRefPubMedGoogle Scholar
  30. 30.
    Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, et al. Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention. 2013;9:204–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997;96:1882–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg. 1999;89:849–55.PubMedGoogle Scholar
  33. 33.
    Hassan SA, Hlatky MA, Boothroyd DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med. 2001;110:260–6.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of MedicineSpijkenisse MCSpijkenisseThe Netherlands

Personalised recommendations